eGenesis Company
Xenotransplant
Investors
Headquarters:
USA
Founded Date:
2014
Last Funding Type:
Series C
Investors Number:
27
Last Funding Date:
2021
Estimated Revenue:
$10M to $50M
Employee Number:
11-50
Total Funding:
$265.00
Industry:
Risk Mitigation
Investor Type:
Late Stage Venture